Clin2
NCT05637086Possibly a fitRecruiting

Test pentoxifylline plus celecoxib for grand mal epilepsy on phenytoin

Epilepsy

Treatments studied

Part of Brain & nervous system clinical trials.

This Phase 2 study tests whether adding two medicines—pentoxifylline and celecoxib—to current phenytoin treatment is safe and may help people with grand mal (generalized) epilepsy. It focuses mainly on safety while you stay on a single epilepsy medicine.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
90 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You have grand mal (generalized) epilepsy and take phenytoin alone (no other seizure medicines)
  • If you can become pregnant: your pregnancy test is negative and you use reliable birth control
  • Your liver and kidney tests are not significantly abnormal
  • You do not have allergies to pentoxifylline or celecoxib (or known sulfonamide allergies)
  • You should not have certain heart disease history, blood-bleeding events, or be on banned medicines

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07228338Not yet recruiting· Early Phase 1
Testing a memory-boosting drug in epilepsy surgery patients

This study tests whether a medication called COBENFY (trospium chloride) can improve memory and brain wave activity in adults with epilepsy who are already scheduled for brain surgery with electrodes. It aims to see if enhancing a brain chemical called acetylcholine helps with memory and seizure focus.

Dallas, Texas
NCT07046676Recruiting· Phase 4
Using genetics to personalize valproate treatment for epilepsy

This trial studies how a person's genes affect their response to the epilepsy drug valproate. The goal is to find the best dose for each patient to improve seizure control and reduce side effects.

Hengyang, Hunan
NCT06794606Recruiting
Study for drug-resistant focal epilepsy

This trial looks at ways to diagnose and treat focal epilepsy that isn't controlled by medications. It includes patients with or without a visible brain lesion on imaging.

Milan
NCT05575505Recruiting· Phase 2
Pentoxifylline added to ulcerative colitis treatment

This trial tests whether adding the medicine pentoxifylline to standard care can help people with ulcerative colitis. It’s designed to see if this combination improves symptoms by changing inflammation.

Al Mansurah
NCT07349472Recruiting· Phase 2
Pentoxifylline for ulcerative colitis

This trial tests if the drug pentoxifylline can help people with mild to moderate ulcerative colitis. It may offer a new treatment option for those not on other strong medications.

Al Fayyum
NCT06998628Recruiting· Phase 2
Pentoxifylline for rheumatoid arthritis inflammation

This study tests if pentoxifylline, a medicine typically used for circulation, can help reduce joint inflammation in people with rheumatoid arthritis who still have active symptoms despite taking standard DMARDs.

Damietta, Damietta Governorate

Hear when a new Epilepsy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.